Skip to main content
GRDN logo

Guardian Pharmacy Services, Inc.

GRDNNYSEHealthcareMedical Care Facilities

$39.68Today:- (-)1Y +62.82%

As of Oct 15, 2026 close

Market cap
$2.53B
P/E (TTM)
38.43
Forward P/E
-
Dividend yield
-
52-week range
$23.37$48.33
Volume (live)
-
Avg. volume (3M)
629.91K

Guardian Pharmacy Services (GRDN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Guardian Pharmacy Services generated $100.25M of operating cash flow and spent $19.55M on capital expenditures. That left free cash flow of $80.71M, up 94.1% from $41.59M a year earlier, or 5.6% of revenue. It repurchased $29.04M of its own shares.

Guardian Pharmacy Services Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Guardian Pharmacy Services, Inc. (GRDN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income49.22-71.0337.7249.6628.3329.6631.3723.27
Depreciation & Amortization22.3419.7718.2316.5616.5317.2615.8513.13
Deferred Income Tax3.070.000.000.000.000.000.000.00
Stock Based Compensation13.85131.49-6.09-3.3813.033.211.935.98
Change in Working Capital6.38-29.4115.60-18.72-1.47-1.091.34-1.66
Change in Accounts Receivable-8.55-25.49-14.30-16.79-7.713.58-11.13-8.79
Change in Inventory-0.88-1.154.43-8.12-0.240.38-3.050.48
Change in Accounts Payable16.4013.236.3013.379.78-1.957.919.05
Change in Other Working Capital1.080.770.28-7.17-3.30-3.107.61-2.39
Other Operating Activities1.080.770.284.402.083.585.672.95
Net Cash from Operating Activities100.2657.9670.8248.5258.5052.6156.1643.68
Investing Activities
Capital Expenditures-19.55-16.37-14.56-16.77-9.28-8.34-14.54-10.01
Acquisitions-13.42-14.71-0.99-2.00-4.40-4.38-2.07-10.68
Other Investing Activities-12.680.672.100.870.540.550.02-0.06
Net Cash from Investing Activities-32.23-30.41-13.44-17.90-13.15-12.18-16.59-20.75
Financing Activities
Debt Repayment-4.98-240.78-272.39-2.80-6.10-13.372.3016.03
Common Stock Issued29.04119.780.000.000.000.000.000.00
Common Stock Repurchased-29.04-55.180.000.000.000.000.000.00
Dividends Paid0.00-35.75-38.42-30.80-17.36-10.82-34.32-27.99
Other Financing Activities-2.09-16.02-15.92-11.42-13.34-10.07-9.52-9.11
Net Cash from Financing Activities-7.07-23.65-57.23-45.03-36.79-34.26-41.55-21.08
Summary
Net Change in Cash60.963.910.15-14.418.566.17-1.981.85
Cash at Beginning of Period4.660.750.6115.016.450.282.250.40
Cash at End of Period65.624.660.750.6115.016.450.282.25
Free Cash Flow80.7141.5956.2631.7549.2244.2741.6233.67
Supplemental Disclosures
Interest Paid-3.122.781.78-2.08--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Guardian Pharmacy Services Cash Flow

What is Guardian Pharmacy Services's free cash flow?

Guardian Pharmacy Services generated free cash flow of $80.71M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $100.25M minus $19.55M of capital expenditures. That was up 94.1% from $41.59M a year earlier. Free cash flow equaled 5.6% of revenue.

How much does Guardian Pharmacy Services spend on capital expenditures?

Guardian Pharmacy Services spent $19.55M on capital expenditures in fiscal 2025, compared with $16.37M a year earlier. That equals 19.5% of operating cash flow.

Does Guardian Pharmacy Services pay dividends or buy back shares?

Yes. In fiscal 2025 Guardian Pharmacy Services returned $29.04M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition